Johnson & Johnson
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$652.4M
Q ending 2026-03-31
Prior quarter
$555.0M
Q ending 2025-12-31
Change
+17.5% QoQ · +90.8% YoY
Positions
16
reported holdings
Largest positions
All 16 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Protagonist Therapeutics Inc. | PTGX | Shares | $258.1M | 2.4M |
| Nanobiotix S.A. | NBTX | Shares | $173.6M | 5.6M |
| Meiragtx Holdings Plc | Shares | $57.5M | 6.6M | |
| Rapport Therapeutics, Inc. | RAPP | Shares | $55.8M | 1.8M |
| Cvrx, Inc. | CVRX | Shares | $38.1M | 4.0M |
| Contineum Therapeutics Inc. | CTNM | Shares | $25.8M | 2.0M |
| Legend Biotech Corporation | LEGN | Shares | $14.7M | 815K |
| Xencor, Inc. | XNCR | Shares | $9.0M | 748K |
| Procept Biorobotics Corporation | PRCT | Shares | $9.0M | 358K |
| Fate Therapeutics, Inc. | FATE | Shares | $4.1M | 3.4M |
| Neumora Therapeutics, Inc. | NMRA | Shares | $3.6M | 1.8M |
| Rallybio Corporation | RLYB | Shares | $1.4M | 153K |
| Vor Biopharma, Inc. | VOR | Shares | $959K | 54K |
| Standard Biotools, Inc. | LAB | Shares | $287K | 312K |
| Nano-X Imaging Ltd. | Shares | $190K | 84K | |
| Adicet Bio, Inc. | ACET | Shares | $155K | 23K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.